Axially Chiral Sulfonic Acids for Atroposelective Synthesis of C–N Axially Chiral 1,2‐Diarylbenzimidazoles
Advanced Synthesis & Catalysis · 17.11.2026 · 368 (22)
DOI: 10.1002/adsc.70870 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Synthesis & Catalysis, online erschienen am 12.11.2026. Verfasst von Jana Musilová und 6 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Axially chiral sulfonic acids are introduced as a new class of organocatalysts for atroposelective synthesis. Cyclization of structurally diverse o ‐phenylenediamines with aromatic and heteroaromatic aldehydes efficiently afforded 29 C–N axially chiral 1,2‐diarylbenzimidazoles in enantiomeric ratios of up to 16:84 using only 2.5 mol % catalyst. Investigation of substrate effects revealed that substituents located in the immediate vicinity of the developing C–N chiral axis play a key role in stereocontrol. The enantiomeric ratios were readily enhanced by simple recrystallization, exceeding 99:1 in several cases.
Zitieren
APA
Musilová, J., Přibylka, A., Tomanová, M., Srovnalová, A., Matelová, E., Nemec, I., & Cankař, P. (2026). Axially Chiral Sulfonic Acids for Atroposelective Synthesis of C–N Axially Chiral 1,2‐Diarylbenzimidazoles. Advanced Synthesis & Catalysis, 368(22). https://doi.org/10.1002/adsc.70870
Vancouver
Musilová J, Přibylka A, Tomanová M, Srovnalová A, Matelová E, Nemec I, et al. Axially Chiral Sulfonic Acids for Atroposelective Synthesis of C–N Axially Chiral 1,2‐Diarylbenzimidazoles. Advanced Synthesis & Catalysis. 2026;368(22). doi:10.1002/adsc.70870
BibTeX
@article{Musilov2026,
author = {Musilová, Jana and Přibylka, Adam and Tomanová, Monika and Srovnalová, Adéla and Matelová, Eva and Nemec, Ivan and Cankař, Petr},
title = {Axially Chiral Sulfonic Acids for Atroposelective Synthesis of C–N Axially Chiral 1,2‐Diarylbenzimidazoles},
journal = {Advanced Synthesis & Catalysis},
year = {2026},
volume = {368},
number = {22},
doi = {10.1002/adsc.70870}
}
EUVIMED